Peter C. Harris

Active 1983–2025

212
Papers
34,424
Citations
106
h-index
206
i10-index

Citations

Citations per year for Peter C. Harris1986: 1 citations1987: 6 citations1988: 5 citations1989: 2 citations1990: 9 citations1991: 35 citations1992: 33 citations1993: 34 citations1994: 25 citations1995: 33 citations1996: 45 citations1997: 100 citations1998: 59 citations1999: 97 citations2000: 103 citations2001: 137 citations2002: 115 citations2003: 158 citations2004: 174 citations2005: 187 citations2006: 236 citations2007: 270 citations2008: 279 citations2009: 286 citations2010: 356 citations2011: 230 citations2012: 195 citations2013: 221 citations2014: 304 citations2015: 246 citations2016: 205 citations2017: 232 citations2018: 270 citations2019: 888 citations2020: 934 citations2021: 917 citations2022: 789 citations2023: 453 citations2024: 898 citations2025: 537 citations2026: 2 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,340 citing papers, 33% of this breakdownUnited Kingdom: 577 citing papers, 8.1% of this breakdownGermany: 427 citing papers, 6% of this breakdownChina: 421 citing papers, 5.9% of this breakdownFrance: 359 citing papers, 5.1% of this breakdownItaly: 325 citing papers, 4.6% of this breakdownNetherlands: 297 citing papers, 4.2% of this breakdownCanada: 273 citing papers, 3.8% of this breakdownJapan: 189 citing papers, 2.7% of this breakdownBelgium: 161 citing papers, 2.3% of this breakdownSpain: 161 citing papers, 2.3% of this breakdownAustralia: 133 citing papers, 1.9% of this breakdown
0%33%Other 20.1%

Fields

  • Biochemistry, Genetics and Molecular Biology61.1%
  • Medicine32.6%
  • Neuroscience2.1%
  • Agricultural and Biological Sciences0.9%
  • Immunology and Microbiology0.7%
  • Engineering0.6%
  • Other2%

Topics

  • Genetic and Kidney Cyst Diseases14.5%
  • Renal and related cancers7.8%
  • Biomedical Research and Pathophysiology3.1%
  • Genetic Syndromes and Imprinting2.6%
  • Renal Diseases and Glomerulopathies2.4%
  • Hedgehog Signaling Pathway Studies1.8%
  • Other67.8%

Coauthors

All papers

Open in search
  1. Polycystic kidney disease

    Authors: , , , , , - Nature Reviews Disease Primers 2018 cited by 782

  2. Genetics in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jeffrey B. Kopp, Matthias Kretzler, Matthew B. Lanktree, Beata S. Lipska‐Ziętkiewicz, Kathy Nicholls, Kandai Nozu, Akinlolu Ojo, Afshin Parsa, Cristian Pattaro, York Pei, Martin R. Pollak, Eugene P. Rhee, Simone Sanna‐Cherchi, Judy Savige, John A. Sayer, Francesco Scolari, John R. Sedor, Xueling Sim, Stefan Somlo, Katalin Suszták, Bamidele O. Tayo, Roser Torrá, Albertien M. van Eerde, André Weinstock, Cheryl A. Winkler, Matthias Wuttke, Hong Zhang, Jennifer King, Michael Cheung, Michel Jadoul, Wolfgang C. Winkelmayer­, Ali G. Gharavi - Kidney International 2022 cited by 187

  3. Imaging Classification of Autosomal Dominant Polycystic Kidney Disease

    Authors: , , , , , , , , , , , , , , , - Journal of the American Society of Nephrology 2014 cited by 616

  4. The genetics of kidney stone disease and nephrocalcinosis

    Authors: , , , - Nature Reviews Nephrology 2021 cited by 226

  5. Prevalence Estimates of Polycystic Kidney and Liver Disease by Population Sequencing

    Authors: , , , , , , , - Journal of the American Society of Nephrology 2018 cited by 309

  6. Genetic Complexity of Autosomal Dominant Polycystic Kidney and Liver Diseases

    Authors: , , - Journal of the American Society of Nephrology 2017 cited by 401

  7. Monoallelic IFT140 pathogenic variants are an important cause of the autosomal dominant polycystic kidney-spectrum phenotype

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - The American Journal of Human Genetics 2021 cited by 168

  8. Mutations in GANAB , Encoding the Glucosidase IIα Subunit, Cause Autosomal-Dominant Polycystic Kidney and Liver Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - The American Journal of Human Genetics 2016 cited by 469

  9. Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity

    Authors: , , , , , , , , - Journal of Clinical Investigation 2012 cited by 451

  10. Volume Progression in Polycystic Kidney Disease

    Authors: , , , , , , , , , , , , , , , , - New England Journal of Medicine 2006 cited by 792

  11. Autosomal dominant polycystic kidney disease

    Authors: , , - The Lancet 2007 cited by 1,532

  12. Blood Pressure in Early Autosomal Dominant Polycystic Kidney Disease

    Authors: , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2014 cited by 517

  13. Monoallelic Mutations to DNAJB11 Cause Atypical Autosomal-Dominant Polycystic Kidney Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - The American Journal of Human Genetics 2018 cited by 313

  14. Phenotype-Genotype Correlations and Estimated Carrier Frequencies of Primary Hyperoxaluria

    Authors: , , , , , , , , - Journal of the American Society of Nephrology 2015 cited by 263

  15. Overweight and Obesity Are Predictors of Progression in Early Autosomal Dominant Polycystic Kidney Disease

    Authors: , , , , , , , , , , , , , , , - Journal of the American Society of Nephrology 2017 cited by 173

  16. Polygenic risk alters the penetrance of monogenic kidney disease

    Authors: , , , , , , , - Nature Communications 2023 cited by 64

  17. A Practical Guide for Treatment of Rapidly Progressive ADPKD with Tolvaptan

    Authors: , , , , , , , , , , - Journal of the American Society of Nephrology 2018 cited by 257

  18. Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease

    Authors: , - Journal of Clinical Investigation 2014 cited by 337

  19. Extracellular vesicles and exosomes generated from cystic renal epithelial cells promote cyst growth in autosomal dominant polycystic kidney disease

    Authors: , , , , - Nature Communications 2021 cited by 76

  20. The value of genotypic and imaging information to predict functional and structural outcomes in ADPKD

    Authors: , , , , , , , , , , , , , , , , , - JCI Insight 2020 cited by 86

  21. International consensus statement on the diagnosis and management of autosomal dominant polycystic kidney disease in children and young people

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Nature Reviews Nephrology 2019 cited by 165

  22. Performance of an Artificial Multi-observer Deep Neural Network for Fully Automated Segmentation of Polycystic Kidneys

    Authors: , , , , , , , , - Journal of Digital Imaging, J. Digit. Imaging 2017 cited by 147

  23. Monoallelic pathogenic ALG5 variants cause atypical polycystic kidney disease and interstitial fibrosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - The American Journal of Human Genetics 2022 cited by 71

  24. Polycystic Kidney Disease

    Authors: , - Annual Review of Medicine 2008 cited by 804